Michigan State University Research Foundation, 2025-09-18: MSU Research Foundation statement that cisplatin licensing royalties have produced more than $400 million, with royalties from cisplatin and its derivative carboplatin managed by the Foundation.
Licensing royalties from the life-saving cisplatin treatment have generated more than $400 million for research, startup investment, and innovation programs led by the MSU Research Foundation.
HTML page, unpaginated
Michigan State University Research Foundation, 2025-09-18: MSU Research Foundation statement that cisplatin licensing royalties have produced more than $400 million, with royalties from cisplatin and its derivative carboplatin managed by the Foundation. Funder/conflicts: the publisher is the royalty beneficiary; this is a self-interested institutional source and the figure is unaudited in the document. Maker: n/a. Comparator: n/a. The page gives no year-by-year royalty schedule and no audited financial statement; MSU's Form 990/annual report would be needed to independently corroborate the $400 million. Study type: news.
